Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Carfilzomib weekly 20/56 mg/m2 , lenalidomide and dexamethasone for early relapsed refractory multiple myeloma.

Literature DB >> 30358902

Carfilzomib weekly 20/56 mg/m² , lenalidomide and dexamethasone for early relapsed refractory multiple myeloma.

Valentine Richez¹, Cecile Gruchet², Stephanie Guidez², Guillemette Fouquet³, Isabelle Azais⁴, Geraldine Durand⁴, Vincent Javaugue⁵, Antoine Brigaud⁶, Florent Plasse⁷, Jéremie Diolez⁸, Antoine Machet², Niels Moya², Helene Gardeney², Paul Franques², Arthur Bobin², Anthony Levy², Florence Sabirou², Anthony Bonnin⁷, Celine Dieval⁹, Sylvain Primault¹⁰, Jocelyn Barrier¹⁰, Emmanuel Fleck¹¹, Sabrina Bouyier², Claire Daras¹², Isabelle Princet¹², Delphine Bauwens¹², Laurence Legros¹, Jean-Gabriel Fuzibet¹, Angela Gil¹³, Frank Bridoux⁵, Hervé Avet-Loiseau¹⁴, Xavier Leleu².

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2018 PMID： 30358902 DOI： 10.1002/ajh.25327

Source DB: PubMed Journal: Am J Hematol ISSN： 0361-8609 Impact factor: 10.047

Keyword Cloud
Cited

× No keyword cloud information.

2 in total

1. How are patient-reported outcomes and symptoms being measured in adults with relapsed/refractory multiple myeloma? A systematic review.

Authors: Matthew R LeBlanc; Rachel Hirschey; Ashley Leak Bryant; Thomas W LeBlanc; Sophia K Smith
Journal: Qual Life Res Date: 2019-12-17 Impact factor: 4.147

2. Weekly carfilzomib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: A phase 1b study.

Authors: Noa Biran; David Siegel; Jesus G Berdeja; Noopur Raje; Robert Frank Cornell; Melissa Alsina; Tibor Kovacsovics; Belle Fang; Amy S Kimball; Ola Landgren
Journal: Am J Hematol Date: 2019-05-13 Impact factor: 10.047

2 in total